CMTM5 and myeloid sarcoma: As we have previously shown, CMTM5 expression was reduced in animal models recapitulating specific histopathological features of MS such as intrinsic oligodendrocyte degeneration (i.e., Cuprizone model) and inflammatory demyelination (i.e., EAE model) [22].